$CDIO News

Cardio Diagnostics Hldgs Q1 EPS $(0.63) Up From $(0.97) YoY, Sales $2.680K Up From $940.000 YoY

Looking Into Cardio Diagnostics Holdings Inc's Recent Short Interest

CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, February 19, 2026

Cardio Diagnostics Holdings shares are trading higher after the company announced it will host an investor call on February 18. The call was initially scheduled today.

Cardio Diagnostics Holdings shares are trading higher after the company announced it will host an investor call on February 18. The call was initially scheduled today.

Cardio Diagnostics Bets On India To Scale AI Heart Diagnostics

Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD™ Test in India

Cardio Diagnostics, Aimil And Dr. Lal PathLabs Collaborate To Bring PrecisionCHD Coronary Heart Disease Test To Indian Market

Cardio Diagnostics Holdings, Inc. and Southdale YMCA Announce New Heart Health Partnership to Serve the Edina, Minnesota Community

Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)

Cardio Diagnostics Announces Centers for Medicare and Medicaid Services Issued Final Gapfill Payment Rate Of $854 For Epi+Gen CHD And PrecisionCHD Tests

Cardio Diagnostics Holdings, Inc. to Present Data Demonstrating PrecisionCHD’s Ability to Detect INOCA and MINOCA at the American Heart Association Scientific Sessions

Cardio Diagnostics' PrecisionCHD Test To Detect Hidden Forms Of Heart Disease INOCA And MINOCA, To Be Presented At AHA Sessions

Cardio Diagnostics Holdings, Inc. and YMCA of East Tennessee Partner to Bring Heart Health Education and Advanced Testing to East Tennessee Community

Cardio Diagnostics Holdings, Inc. Expands Provider Network, Adding 15 New Provider Organizations From Across the United States

Cardio Diagnostics Enters Partnerships With 15 New U.S. Provider Organizations, Expanding Adoption Of Its AI-driven Blood Tests, Epi+Gen CHD And PrecisionCHD Which Aim To Improve Prevention, Detection, And Management Of Coronary Heart Disease Across Diverse Clinical Settings

Cardio Diagnostics Holdings Second Quarter 2025 Earnings: US$0.97 loss per share (vs US$1.71 loss in 2Q 2024)

Cardio Diagnostics Hldgs Q2 EPS $(0.97) Beats $(1.80) Estimate, Sales $7.475K Miss $75.000K Estimate

Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)

Cardio Diagnostics Secures Preliminary Medicare Payment Rates For Epi+Gen CHD And PrecisionCHD, Marking Key Reimbursement Milestone